This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gabbert, H. E. Articles by Luley, C. Search for Related Content PubMed PubMed Citation Articles by Gabbert, H. E. Articles by Luley, C.

Terminal Differentiation and Growth Inhibition of a Rat Rhabdomyosarcoma Cell Line (BA-HAN-1C) in Vitro after Exposure to Retinoic Acid¹

Departments of Pathology [H. E. G., C-D. G., R. E.], Biochemistry [H-K. B.], and Internal Medicine [C. L.], Johannes Gutenberg-University of Mainz, D-6500 Mainz, Federal Republic of Germany

BA-HAN-1C is a clonal rat rhabdomyosarcoma cell line composed of proliferating mononuclear cells, which partly fuse to terminally differentiated postmitotic myotube-like giant cells. The exposure to retinoic acid in vitro resulted in time- and dose-dependent changes of both cell differentiation and cell growth. The mononuclear cells revealed bundles of newly formed thick and thin myofilaments, never observed in untreated cultures, and exhibited signs of contact inhibition. In addition, there was a statistically significant increase (P < 0.001) in the number of terminally differentiated postmitotic myotube-like giant cells and in the creatine kinase activity (P < 0.05) which was used as a biochemical differentiation marker. At the same time cell growth was significantly inhibited (P < 0.001) in vitro and a decrease in plating efficiency, as well as in saturation density, was observed. These data demonstrate that retinoic acid can suppress cell growth and simultaneously initiate differentiation in a malignant mesenchymal tumor cell line. However, despite the clonal nature of BA-HAN-1C, the complete status of terminal differentiation was not achieved by all tumor cells. The reason why not all tumor cells responded to retinoic acid is unknown at the present time and will have to be the subject of further studies.

¹ Some of the results are part of the medical thesis of R. Engers.

² To whom requests for reprints should be addressed, at Department of Pathology, University of Mainz, Langenbeckstr. 1, D-6500 Mainz, FRG.

Received 12/ 7/87. Revised 5/16/88. Accepted 6/ 8/88.

This article has been cited by other articles:

				J. Janinis, M. Patriki, L. Vini, G. Aravantinos, and J. S. Whelan The pharmacological treatment of aggressive fibromatosis: a systematic review Ann. Onc., February 1, 2003; 14(2): 181 - 190. [Abstract] [Full Text] [PDF]

				Y. Yoshiko, K. Hirao, and N. Maeda Differentiation in C2C12 myoblasts depends on the expression of endogenous IGFs and not serum depletion Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1278 - C1286. [Abstract] [Full Text] [PDF]

				P. Elsner, B. Quistorff, T. S. Hermann, J. Dich, and N. Grunnet Regulation of glycogen accumulation in L6 myotubes cultured under optimized differentiation conditions Am J Physiol Endocrinol Metab, December 1, 1998; 275(6): E925 - E933. [Abstract] [Full Text] [PDF]